These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8584992

  • 1. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P.
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [Abstract] [Full Text] [Related]

  • 2. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W, Warfarin Optimal Duration Italian Trial Investigators.
    N Engl J Med; 2001 Jul 19; 345(3):165-9. PubMed ID: 11463010
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.
    Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, Julian J.
    Thromb Haemost; 1998 Jan 19; 79(1):19-22. PubMed ID: 9459315
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
    Vorob'eva NM, Ermolina OV, Balakhonova TV, Dobrovol'skiĭ AB, Titaeva EV, Kirienko AI, Panchenko EP.
    Ter Arkh; 2008 Jan 19; 80(7):50-4. PubMed ID: 18763596
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.
    Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H.
    N Engl J Med; 1995 Jun 22; 332(25):1661-5. PubMed ID: 7760866
    [Abstract] [Full Text] [Related]

  • 11. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT, Hunt N, Strachan RK, Nicolaides AN.
    Thromb Haemost; 2001 Sep 22; 86(3):817-21. PubMed ID: 11583313
    [Abstract] [Full Text] [Related]

  • 12. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug 22; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Aug 22; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 14. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F, Escribá A, Maluenda MP, López Rubio M, Margalet I, Lezana A, Gallego J, Ribera JM.
    Thromb Haemost; 2000 Oct 22; 84(4):559-64. PubMed ID: 11057850
    [Abstract] [Full Text] [Related]

  • 15. Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.
    Harenberg J, Ingrid J, Tivadar F.
    Isr Med Assoc J; 2002 Nov 22; 4(11):1003-5. PubMed ID: 12489490
    [Abstract] [Full Text] [Related]

  • 16. [The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism].
    Yang P, Wu QH, Luo XY, Kou L, Chen Z, Zhang YY, Zhou H.
    Zhonghua Yi Xue Za Zhi; 2009 Jul 07; 89(25):1762-5. PubMed ID: 19862981
    [Abstract] [Full Text] [Related]

  • 17. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R, Delmore T, Carter C, Hirsh J, Genton E, Gent M, Turpie G, McLaughlin D.
    N Engl J Med; 1982 Jan 28; 306(4):189-94. PubMed ID: 7033782
    [Abstract] [Full Text] [Related]

  • 18. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement.
    Francis CW, Pellegrini VD, Leibert KM, Totterman S, Azodo MV, Harris CM, Cox C, Marder VJ.
    Thromb Haemost; 1996 May 28; 75(5):706-11. PubMed ID: 8725709
    [Abstract] [Full Text] [Related]

  • 19. Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.
    Koscielny J, Kiesewetter H, Jörg I, Harenberg J.
    Clin Appl Thromb Hemost; 2007 Jul 28; 13(3):299-307. PubMed ID: 17636192
    [Abstract] [Full Text] [Related]

  • 20. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
    Hull RD, Raskob GE, Rosenbloom D, Panju AA, Brill-Edwards P, Ginsberg JS, Hirsh J, Martin GJ, Green D.
    N Engl J Med; 1990 May 03; 322(18):1260-4. PubMed ID: 2183055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.